西澳大利亚膀胱癌诊断与初始治疗延迟分析
该研究回顾性分析了西澳大利亚一家公立三级医院2008年5月至2014年4月一站式血尿门诊的所有就诊者,量化膀胱癌诊断与初始治疗的延迟并探讨原因。1365例就诊者中151例诊断为膀胱肿瘤,100例参与研究;可见血尿患者从首次出血到手术的中位等待时间为69.5天。延迟原因包括公众意识差、患者恐惧焦虑、初级保健转诊延迟或未转诊、行政延迟及资源限制。
要点
- 可见血尿患者从首次出血到手术的中位等待时间为69.5天(范围9-1165天)。
- 等待时间由转诊前12天、评估23.5天、治疗20天组成(均为中位数)。
- 延迟原因包括公众意识差、患者恐惧焦虑、转诊延迟或未转诊、行政延迟及资源限制。
核心结论
- 西澳大利亚许多膀胱癌患者在诊断和治疗方面经历显著延迟,这可能反映全国趋势;这些令人担忧的数据值得考虑如何减少延迟以改善患者结局。
研究设计与样本
- 回顾性审查2008年5月至2014年4月期间西澳大利亚一家公立三级医院一站式血尿门诊的所有就诊记录,识别该期间诊断为膀胱肿瘤的患者,并回顾性联系患者及其全科医生进行电话访谈,必要时从临床记录补充数据;对可见血尿患者确定就诊、转诊、评估和初始治疗的等待时间。
主要发现
- 1365例就诊者中151例诊断为膀胱肿瘤,其中100例既符合条件又同意参与研究。
- 可见血尿患者从首次出血到手术的中位(范围)等待时间为69.5(9-1165)天。
- 等待时间包括转诊前中位(范围)12(0-1137)天、评估等待中位(范围)23.5(0-207)天、治疗等待中位(范围)20(1-69)天。
- 等待时间延长的原因包括公众意识差、患者恐惧和焦虑、初级保健转诊延迟和未转诊、行政延迟及资源限制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To quantify and examine the causes of delays in the diagnosis and initial treatment of patients with bladder cancer in Western Australia. SUBJECTS AND METHODS: All attendances at a one-stop haematuria clinic at a public tertiary-level hospital in Western Australia between May 2008 and April 2014 were reviewed retrospectively. All patients diagnosed with a bladder tumour over this period were identified. These patients and their general practitioners were contacted retrospectively and invited to participate in telephone interviews, with additional data collected from clinical records as required. Waiting times to presentation, referral, assessment, and initial treatment were established for patients who presented with visible haematuria. RESULTS: Of 1 365 attendances, 151 patients were diagnosed with a bladder tumour and 100 of these were both suitable and agreed to participate in the study. For patients with visible haematuria the median (range) waiting time from initial bleeding to surgery was 69.5 (9-1 165) days. This was comprised of a median (range) pre-referral waiting time of 12 (0-1 137) days, assessment waiting time of 23.5 (0-207) days, and treatment waiting time of 20 (1-69) days. Reasons for prolonged waiting times included poor public awareness, patient fear and anxiety, delayed and non-referral from primary care, administrative delays, and resource limitations. CONCLUSION: Many patients experience significant delays in the diagnosis and treatment of their bladder cancer in Western Australia, and this probably reflects national trends. These concerning data warrant consideration of how delays can be reduced to improve outcomes for these patients.
引用
- McCombie SP, Bangash HK, Kuan M, et al. Delays in the diagnosis and initial treatment of bladder cancer in Western Australia. BJU Int. 2017. PMID: 28661572. doi:10.1111/bju.13939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。